hsa-miR-181a

ncRNA information

ncRNA name

hsa-miR-181a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Prostate Cancer

Cancer site

Prostate

Treatment information

Treatment type

Chemotherapy

Drug

Docetaxel

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.

Tissue resource

prostate cancer cell lines C4-2B

prostate cancer paclitaxel-resistant cell lines TaxR

prostate cancer cell lines DU145

prostate cancer paclitaxel-resistant cell lines DU145-DTXR

Experiment

qRT-PCR,Western blot


Institute

Cedars-Sinai Medical Center

University of California Davis

Country

USA

Continent

Amercia